XNAS 15 Oct, 2026 10:51 AM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Mr. Mark Hopman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 18.96 per share. | 01 Oct 2026 | 370 | 56,109 | - | 19.0 | 7,015 | - |
| Ms. Christy Jones | Director | Sale of securities on an exchange or to another person at price $ 23.00 per share. | 22 Sep 2026 | 6,430 | 19,564 | - | 23 | 147,890 | - |
| Mr. Mike Mensinger | Chief Product Officer | Sale of securities on an exchange or to another person at price $ 22.00 per share. | 16 Sep 2026 | 2,650 | 177,390 | - | 22 | 58,300 | Common Stock |
| Mr. Mark Hopman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 20.13 per share. | 16 Sep 2026 | 30,779 | 56,479 | - | 20.1 | 619,640 | Common Stock |
| Mr. Mark Hopman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 15.52 per share. | 14 Sep 2026 | 775 | 86,382 | - | 15.5 | 12,028 | Common Stock |
| Mr. Mark Hopman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 18.46 per share. | 09 Sep 2026 | 36,870 | 87,157 | - | 18.5 | 680,723 | Common Stock |
| Mr. Mark Hopman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 18.46 per share. | 09 Sep 2026 | 35,994 | 88,033 | - | 18.5 | 664,550 | Common Stock |
| Mr. Sean Saint | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 20.08 per share. | 03 Sep 2026 | 5,641 | 398,429 | - | 20.1 | 113,259 | Common Stock |
| Mr. Sean Saint | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 19.11 per share. | 02 Sep 2026 | 16,867 | 404,070 | - | 19.1 | 322,381 | Common Stock |
| Mr. Stephen Feider | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 19.11 per share. | 02 Sep 2026 | 6,675 | 159,378 | - | 19.1 | 127,580 | Common Stock |
| Mr. Mike Mensinger | Chief Product Officer | Sale of securities on an exchange or to another person at price $ 19.11 per share. | 02 Sep 2026 | 4,375 | 180,040 | - | 19.1 | 83,620 | Common Stock |
| Dr. Steven Russell, M.D.,PhD | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 19.11 per share. | 02 Sep 2026 | 4,221 | 169,628 | - | 19.1 | 80,676 | Common Stock |
| Mr. Mark Hopman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 19.11 per share. | 02 Sep 2026 | 5,327 | 124,027 | - | 19.1 | 101,815 | Common Stock |
| Mr. Stephen Feider | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.10 per share. | 26 Jun 2026 | 4,982 | 171,035 | - | 5.1 | 25,408 | Common Stock |
| Mr. Stephen Feider | Chief Financial Officer | 26 Jun 2026 | 4,896 | 39,817 | - | - | Employee Stock Option (right to buy) | ||
| Mr. Stephen Feider | Chief Financial Officer | 26 Jun 2026 | 4,982 | 44,713 | - | - | Employee Stock Option (right to buy) | ||
| Mr. Stephen Feider | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 17.03 per share. | 26 Jun 2026 | 4,896 | 165,931 | - | 17.0 | 83,381 | Common Stock |
| Mr. Stephen Feider | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.10 per share. | 26 Jun 2026 | 4,896 | 170,827 | - | 5.1 | 24,970 | Common Stock |
| Mr. Stephen Feider | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 17.05 per share. | 26 Jun 2026 | 5,104 | 165,931 | - | 17.0 | 87,006 | Common Stock |
| Mr. Stephen Feider | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.10 per share. | 26 Jun 2026 | 5,104 | 171,157 | - | 5.1 | 26,030 | Common Stock |
| Mr. Stephen Feider | Chief Financial Officer | 26 Jun 2026 | 4,896 | 39,695 | - | - | Employee Stock Option (right to buy) | ||
| Mr. Stephen Feider | Chief Financial Officer | 26 Jun 2026 | 5,104 | 44,591 | - | - | Employee Stock Option (right to buy) | ||
| Mr. Stephen Feider | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 17.03 per share. | 26 Jun 2026 | 4,896 | 166,053 | - | 17.0 | 83,381 | Common Stock |
| Mr. Stephen Feider | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.10 per share. | 26 Jun 2026 | 4,896 | 170,949 | - | 5.1 | 24,970 | Common Stock |
| Mr. Stephen Feider | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 17.05 per share. | 26 Jun 2026 | 5,104 | 166,053 | - | 17.0 | 87,006 | Common Stock |
| Ms. Christy Jones | Director | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 24 Jun 2026 | 1,406 | 25,994 | - | 15 | 21,090 | Common Stock |
| Mr. Mark Hopman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 15.01 per share. | 24 Jun 2026 | 1,258 | 129,354 | - | 15.0 | 18,880 | Common Stock |
| Ms. Christy Jones | Director | Sale of securities on an exchange or to another person at price $ 14.00 per share. | 04 Jun 2026 | 2,811 | 27,400 | - | 14 | 39,354 | Common Stock |
| Mr. Mark Hopman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 12.31 per share. | 04 Jun 2026 | 275 | 130,612 | - | 12.3 | 3,385 | Common Stock |
| Mr. Sean Saint | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 12.61 per share. | 02 Jun 2026 | 16,872 | 420,937 | - | 12.6 | 212,707 | Common Stock |
| Mr. Stephen Feider | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 12.61 per share. | 02 Jun 2026 | 6,676 | 166,053 | - | 12.6 | 84,165 | Common Stock |
| Mr. Mike Mensinger | Chief Product Officer | Sale of securities on an exchange or to another person at price $ 12.61 per share. | 02 Jun 2026 | 4,378 | 184,415 | - | 12.6 | 55,194 | Common Stock |
| Dr. Steven Russell, M.D.,PhD | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 12.61 per share. | 02 Jun 2026 | 4,222 | 173,849 | - | 12.6 | 53,227 | Common Stock |
| Mr. Mark Hopman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 12.61 per share. | 02 Jun 2026 | 5,329 | 130,887 | - | 12.6 | 67,183 | Common Stock |
| Mr. Sean D. Carney | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2026 | 16,965 | 32,209 | - | 0 | Common Stock | |
| Mr. Gerard J. Michel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2026 | 16,965 | 33,509 | - | 0 | Common Stock | |
| Mr. Danny Lee Dearen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2026 | 16,965 | 32,209 | - | 0 | Common Stock | |
| Dr. Maria Palasis, PhD | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2026 | 16,965 | 29,397 | - | 0 | Common Stock | |
| Mr. Adam Lezack, PhD | Director | Sale of securities on an exchange or to another person at price $ 11.21 per share. | 21 May 2026 | 998 | 27,399 | - | 11.2 | 11,188 | Comon Stock |
| Mr. Adam Lezack, PhD | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2026 | 16,965 | 28,397 | - | 0 | Common Stock | |
| Mr. Adam Lezack, PhD | Director | Sale of securities on an exchange or to another person at price $ 9.95 per share. | 21 May 2026 | 1,000 | 11,432 | - | 10.0 | 9,950 | Common Stock |
| Ms. Christy Jones | Director | Sale of securities on an exchange or to another person at price $ 9.95 per share. | 21 May 2026 | 1,998 | 13,246 | - | 9.9 | 19,880 | Common Stock |
| Ms. Christy Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2026 | 16,965 | 30,211 | - | 0 | Common Stock | |
| Mr. Mark Hopman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 11.57 per share. | 04 Mar 2026 | 353 | 139,133 | - | 11.6 | 4,084 | Common Stock |
| Mr. Sean Saint | Director, President & CEO | 27 Feb 2026 | 184,837 | 184,837 | - | - | Employee Stock Option (right to buy) | ||
| Mr. Sean Saint | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2026 | 343,269 | 441,193 | - | 0 | Common Stock | |
| Mr. Sean Saint | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 12.36 per share. | 27 Feb 2026 | 3,384 | 437,809 | - | 12.4 | 41,832 | Common Stock |
| Mr. Stephen Feider | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2026 | 131,543 | 174,157 | - | 0 | Common Stock | |
| Mr. Stephen Feider | Chief Financial Officer | 27 Feb 2026 | 70,831 | 70,831 | - | - | Employee Stock Option (right to buy) | ||
| Mr. Stephen Feider | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 12.36 per share. | 27 Feb 2026 | 1,428 | 172,729 | - | 12.4 | 17,652 | Common Stock |
| Mr. Mike Mensinger | Chief Product Officer | Sale of securities on an exchange or to another person at price $ 12.36 per share. | 27 Feb 2026 | 1,064 | 188,793 | - | 12.4 | 13,153 | Common Stock |
| Mr. Mike Mensinger | Chief Product Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2026 | 109,105 | 189,857 | - | 0 | Common Stock | |
| Mr. Mike Mensinger | Chief Product Officer | 27 Feb 2026 | 58,749 | 58,749 | - | - | Employee Stock Option (right to buy) | ||
| Dr. Steven Russell, M.D.,PhD | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 12.36 per share. | 27 Feb 2026 | 1,026 | 179,096 | - | 12.4 | 12,683 | Common Stock |
| Dr. Steven Russell, M.D.,PhD | Chief Medical Officer | 27 Feb 2026 | 58,749 | 58,749 | - | - | Employee Stock Option (right to buy) | ||
| Dr. Steven Russell, M.D.,PhD | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2026 | 109,105 | 180,122 | - | 0 | Common Stock | |
| Mr. Mark Hopman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 12.36 per share. | 27 Feb 2026 | 834 | 139,486 | - | 12.4 | 10,310 | Common Stock |
| Mr. Mark Hopman | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2026 | 109,105 | 140,320 | - | 0 | Common Stock | |
| Mr. Mark Hopman | Chief Commercial Officer | 27 Feb 2026 | 58,749 | 58,749 | - | - | Employee Stock Option (right to buy) | ||
| Mr. Sean Saint | Director, President & CEO | 27 Feb 2026 | 287,944 | 287,944 | - | - | Employee Stock Option (right to buy) | ||
| Mr. Stephen Feider | Chief Financial Officer | 27 Feb 2026 | 110,342 | 110,342 | - | - | Employee Stock Option (right to buy) | ||
| Mr. Mike Mensinger | Chief Product Officer | 27 Feb 2026 | 91,520 | 91,520 | - | - | Employee Stock Option (right to buy) | ||
| Dr. Steven Russell, M.D.,PhD | Chief Medical Officer | 27 Feb 2026 | 91,520 | 91,520 | - | - | Employee Stock Option (right to buy) | ||
| Mr. Mark Hopman | Chief Commercial Officer | 27 Feb 2026 | 91,520 | 91,520 | - | - | Employee Stock Option (right to buy) | ||
| Mr. Sean D. Carney | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2026 | 3,997 | 15,244 | - | 0 | Common Stock | |
| Mr. Gerard J. Michel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2026 | 3,997 | 16,544 | - | 0 | Common Stock | |
| Mr. Danny Lee Dearen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2026 | 3,997 | 15,244 | - | 0 | Common Stock | |
| Dr. Maria Palasis, PhD | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2026 | 3,997 | 12,432 | - | 0 | Common Stock | |
| Mr. Adam Lezack, PhD | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2026 | 3,997 | 12,432 | - | 0 | Common Stock | |
| Ms. Christy Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2026 | 3,997 | 15,244 | - | 0 | Common Stock | |
| Mr. Mike Mensinger | Chief Product Officer | Sale of securities on an exchange or to another person at price $ 30.10 per share. | 06 Jan 2026 | 2,200 | 80,752 | - | 30.1 | 66,221 | Common Stock |
| Mr. Stephen Feider | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.10 per share. | 02 Jan 2026 | 20,000 | 62,614 | - | 5.1 | 102,000 | Common Stock |
| Mr. Stephen Feider | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 29.53 per share. | 02 Jan 2026 | 20,000 | 42,614 | - | 29.5 | 590,680 | Common Stock |
| Mr. Stephen Feider | Chief Financial Officer | 02 Jan 2026 | 20,000 | 49,695 | - | - | Employee Stock Option (right to buy) | ||
| Mr. Mike Mensinger | Chief Product Officer | Sale of securities on an exchange or to another person at price $ 29.56 per share. | 02 Jan 2026 | 7,200 | 83,552 | - | 29.6 | 212,832 | Common Stock |
| Mr. Mike Mensinger | Chief Product Officer | Sale of securities on an exchange or to another person at price $ 30.20 per share. | 02 Jan 2026 | 600 | 82,952 | - | 30.2 | 18,118 | Common Stock |
| Mr. Stephen Feider | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 29.34 per share. | 02 Dec 2025 | 1,427 | 42,614 | - | 29.3 | 41,862 | Common Stock |
| Mr. Sean Saint | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 29.34 per share. | 02 Dec 2025 | 3,278 | 97,924 | - | 29.3 | 96,163 | Common Stock |
| Mr. Mike Mensinger | Chief Product Officer | Sale of securities on an exchange or to another person at price $ 29.34 per share. | 02 Dec 2025 | 1,063 | 90,752 | - | 29.3 | 31,184 | Common Stock |
| Dr. Steven Russell, M.D.,PhD | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 29.34 per share. | 02 Dec 2025 | 1,025 | 178,071 | - | 29.3 | 30,069 | Common Stock |
| Mr. Mark Hopman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 29.34 per share. | 02 Dec 2025 | 856 | 138,277 | - | 29.3 | 25,112 | Common Stock |
| Mr. Mark Hopman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 30.66 per share. | 02 Dec 2025 | 2,061 | 136,216 | - | 30.7 | 63,192 | Common Stock |
| Dr. Maria Palasis, PhD | Director | Sale of securities on an exchange or to another person at price $ 29.96 per share. | 01 Dec 2025 | 500 | 8,435 | - | 30.0 | 14,982 | Common Stock |
| Dr. Maria Palasis, PhD | Director | Sale of securities on an exchange or to another person at price $ 29.33 per share. | 01 Dec 2025 | 906 | 8,935 | - | 29.3 | 26,570 | Common Stock |
| Mr. Adam Lezack, PhD | Director | Sale of securities on an exchange or to another person at price $ 29.91 per share. | 01 Dec 2025 | 500 | 8,435 | - | 29.9 | 14,955 | Common Stock |
| Mr. Adam Lezack, PhD | Director | Sale of securities on an exchange or to another person at price $ 29.35 per share. | 01 Dec 2025 | 906 | 8,935 | - | 29.3 | 26,588 | Common Stock |
| Dr. Maria Palasis, PhD | Director | Sale of securities on an exchange or to another person at price $ 27.45 per share. | 31 Oct 2025 | 119 | 9,841 | - | 27.5 | 3,267 | Common Stock |
| Dr. Maria Palasis, PhD | Director | Sale of securities on an exchange or to another person at price $ 26.86 per share. | 31 Oct 2025 | 1,287 | 9,960 | - | 26.9 | 34,567 | Common Stock |
| Mr. Adam Lezack, PhD | Director | Sale of securities on an exchange or to another person at price $ 26.85 per share. | 31 Oct 2025 | 1,368 | 9,879 | - | 26.8 | 36,727 | Common Stock |
| Mr. Adam Lezack, PhD | Director | Sale of securities on an exchange or to another person at price $ 27.71 per share. | 31 Oct 2025 | 38 | 9,841 | - | 27.7 | 1,053 | Common Stock |
| Mr. Stephen Feider | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.10 per share. | 03 Oct 2025 | 4,982 | 49,023 | - | 5.1 | 25,408 | Common Stock |
| Mr. Stephen Feider | Chief Financial Officer | 03 Oct 2025 | 4,982 | 69,695 | - | - | Employee Stock Option (right to buy) | ||
| Mr. Stephen Feider | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 22.28 per share. | 03 Oct 2025 | 1,154 | 44,041 | - | 22.3 | 25,709 | Common Stock |
| Mr. Stephen Feider | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 21.52 per share. | 03 Oct 2025 | 3,828 | 45,195 | - | 21.5 | 82,368 | Common Stock |
| Mr. Stephen Feider | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 20.76 per share. | 01 Oct 2025 | 14,918 | 44,141 | - | 20.8 | 309,698 | Common Stock |
| Mr. Stephen Feider | Chief Financial Officer | 01 Oct 2025 | 15,018 | 74,677 | - | - | Employee Stock Option (right to buy) | ||
| Mr. Stephen Feider | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 21.08 per share. | 01 Oct 2025 | 100 | 44,041 | - | 21.1 | 2,108 | Common Stock |
| Mr. Stephen Feider | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.10 per share. | 01 Oct 2025 | 15,018 | 59,059 | - | 5.1 | 76,592 | Common Stock |
| Mr. Stephen Feider | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.10 per share. | 08 Sep 2025 | 9,900 | 53,941 | - | 5.1 | 50,490 | Common Stock |
| Mr. Stephen Feider | Chief Financial Officer | 08 Sep 2025 | 9,900 | 89,695 | - | - | Employee Stock Option (right to buy) | ||
| Mr. Stephen Feider | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 21.13 per share. | 08 Sep 2025 | 9,900 | 44,041 | - | 21.1 | 209,151 | Common Stock |
| Mr. Stephen Feider | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.10 per share. | 05 Sep 2025 | 100 | 44,141 | - | 5.1 | 510 | Common Stock |
| Mr. Stephen Feider | Chief Financial Officer | 05 Sep 2025 | 100 | 99,595 | - | - | Employee Stock Option (right to buy) | ||
| Mr. Stephen Feider | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 21.00 per share. | 05 Sep 2025 | 100 | 44,041 | - | 21 | 2,100 | Common Stock |
| Mr. Mark Hopman | Chief Commercial Officer | 04 Sep 2025 | 656 | 66,428 | - | - | Employee Stock Option (right to buy) | ||
| Mr. Mark Hopman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 20.56 per share. | 04 Sep 2025 | 11,411 | 31,215 | - | 20.6 | 234,657 | Common Stock |
| Mr. Mark Hopman | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.10 per share. | 04 Sep 2025 | 11,411 | 42,626 | - | 5.1 | 58,196 | Common Stock |
| Mr. Mark Hopman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 19.97 per share. | 04 Sep 2025 | 6,818 | 31,215 | - | 20.0 | 136,180 | Common Stock |
| Mr. Mark Hopman | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.10 per share. | 04 Sep 2025 | 4,093 | 38,033 | - | 5.1 | 20,874 | Common Stock |
| Mr. Mark Hopman | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.10 per share. | 04 Sep 2025 | 656 | 33,940 | - | 5.1 | 3,346 | Common Stock |
| Mr. Mark Hopman | Chief Commercial Officer | 04 Sep 2025 | 11,411 | 21,725 | - | - | Employee Stock Option (right to buy) | ||
| Mr. Mark Hopman | Chief Commercial Officer | 04 Sep 2025 | 4,093 | 33,136 | - | - | Employee Stock Option (right to buy) | ||
| Mr. Sean Saint | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 18.86 per share. | 02 Sep 2025 | 3,359 | 101,202 | - | 18.9 | 63,361 | Common Stock |
| Mr. Stephen Feider | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 18.86 per share. | 02 Sep 2025 | 1,462 | 44,041 | - | 18.9 | 27,578 | Common Stock |
| Mr. Mike Mensinger | Chief Product Officer | Sale of securities on an exchange or to another person at price $ 18.86 per share. | 02 Sep 2025 | 1,089 | 91,815 | - | 18.9 | 20,542 | Common Stock |
| Dr. Steven Russell, M.D.,PhD | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 18.86 per share. | 02 Sep 2025 | 1,015 | 71,017 | - | 18.9 | 19,146 | Common Stock |
| Mr. Mark Hopman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 18.86 per share. | 02 Sep 2025 | 848 | 33,284 | - | 18.9 | 15,996 | Common Stock |
| Mr. Stephen Feider | Chief Financial Officer | 22 Aug 2025 | 4,413 | 99,695 | - | - | Employee Stock Option (right to buy) | ||
| Mr. Stephen Feider | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 17.01 per share. | 22 Aug 2025 | 4,413 | 45,503 | - | 17.0 | 75,083 | Common Stock |
| Mr. Stephen Feider | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.10 per share. | 22 Aug 2025 | 4,413 | 49,916 | - | 5.1 | 22,506 | Common Stock |
| Mr. Stephen Feider | Chief Financial Officer | 19 Aug 2025 | 5,587 | 104,108 | - | - | Employee Stock Option (right to buy) | ||
| Mr. Stephen Feider | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.10 per share. | 19 Aug 2025 | 5,587 | 51,090 | - | 5.1 | 28,494 | Common Stock |
| Mr. Stephen Feider | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 17.03 per share. | 19 Aug 2025 | 5,587 | 45,503 | - | 17.0 | 95,172 | Common Stock |
| Mr. Mark Hopman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 16.61 per share. | 19 Aug 2025 | 16,158 | 34,132 | - | 16.6 | 268,376 | Common Stock |
| Mr. Mark Hopman | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.10 per share. | 19 Aug 2025 | 16,158 | 50,290 | - | 5.1 | 82,406 | Common Stock |
| Mr. Mark Hopman | Chief Commercial Officer | 19 Aug 2025 | 16,158 | 67,084 | - | - | Employee Stock Option (right to buy) | ||
| Mr. Sean Saint | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 18.15 per share. | 02 Jun 2025 | 2,185 | 104,872 | - | 18.1 | 39,655 | Common Stock |
| Mr. Sean Saint | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 17.03 per share. | 02 Jun 2025 | 943 | 107,057 | - | 17.0 | 16,057 | Common Stock |
| Mr. Sean Saint | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 18.69 per share. | 02 Jun 2025 | 311 | 104,561 | - | 18.7 | 5,813 | Common Stock |
| Mr. Stephen Feider | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 17.03 per share. | 02 Jun 2025 | 410 | 46,590 | - | 17.0 | 6,981 | Common Stock |
| Mr. Stephen Feider | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 18.69 per share. | 02 Jun 2025 | 136 | 45,503 | - | 18.7 | 2,542 | Common Stock |
| Mr. Stephen Feider | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 18.15 per share. | 02 Jun 2025 | 951 | 45,639 | - | 18.1 | 17,260 | Common Stock |
| Mr. Mike Mensinger | Chief Product Officer | Sale of securities on an exchange or to another person at price $ 18.15 per share. | 02 Jun 2025 | 708 | 93,005 | - | 18.1 | 12,849 | Common Stock |
| Mr. Mike Mensinger | Chief Product Officer | Sale of securities on an exchange or to another person at price $ 18.69 per share. | 02 Jun 2025 | 101 | 92,904 | - | 18.7 | 1,888 | Common Stock |
| Mr. Mike Mensinger | Chief Product Officer | Sale of securities on an exchange or to another person at price $ 17.03 per share. | 02 Jun 2025 | 306 | 93,713 | - | 17.0 | 5,211 | Common Stock |
| Dr. Steven Russell, M.D.,PhD | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 17.03 per share. | 02 Jun 2025 | 285 | 72,786 | - | 17.0 | 4,853 | Common Stock |
| Dr. Steven Russell, M.D.,PhD | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 18.69 per share. | 02 Jun 2025 | 94 | 72,032 | - | 18.7 | 1,757 | Common Stock |
| Dr. Steven Russell, M.D.,PhD | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 18.15 per share. | 02 Jun 2025 | 660 | 72,126 | - | 18.1 | 11,978 | Common Stock |
| Mr. Mark Hopman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 17.03 per share. | 02 Jun 2025 | 238 | 34,762 | - | 17.0 | 4,053 | Common Stock |
| Mr. Mark Hopman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 18.70 per share. | 02 Jun 2025 | 79 | 34,132 | - | 18.7 | 1,477 | Common Stock |
| Mr. Mark Hopman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 18.15 per share. | 02 Jun 2025 | 551 | 34,211 | - | 18.1 | 10,000 | Common Stock |
| Mr. Gerard J. Michel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2025 | 12,547 | 12,547 | - | 0 | Common Stock | |
| Mr. Sean D. Carney | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2025 | 11,247 | 11,247 | - | 0 | Common Stock | |
| Mr. Danny Lee Dearen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2025 | 11,247 | 11,247 | - | 0 | Common Stock | |
| Dr. Maria Palasis, PhD | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2025 | 11,247 | 11,247 | - | 0 | Common Stock | |
| Mr. Adam Lezack, PhD | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2025 | 11,247 | 11,247 | - | 0 | Common Stock | |
| Ms. Christy Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2025 | 11,247 | 11,247 | - | 0 | Common Stock | |
| Mr. Sean Saint | Director, President & CEO | 27 Feb 2025 | 163,000 | 163,000 | - | - | Employee Stock Option (right to buy) | ||
| Mr. Sean Saint | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 108,000 | 108,000 | - | 0 | Common Stock | |
| Mr. Stephen Feider | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 47,000 | 47,000 | - | 0 | Common Stock | |
| Mr. Stephen Feider | Chief Financial Officer | 27 Feb 2025 | 71,000 | 71,000 | - | - | Employee Stock Option (right to buy) | ||
| Mr. Mike Mensinger | Chief Product Officer | 27 Feb 2025 | 52,000 | 52,000 | - | - | Employee Stock Option (right to buy) | ||
| Mr. Mike Mensinger | Chief Product Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 35,000 | 94,019 | - | 0 | Common Stock | |
| Dr. Steven Russell, M.D.,PhD | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 35,000 | 73,071 | - | 0 | Common Stock | |
| Dr. Steven Russell, M.D.,PhD | Chief Medical Officer | 27 Feb 2025 | 52,000 | 52,000 | - | - | Employee Stock Option (right to buy) | ||
| Mr. Mark Hopman | Chief Commercial Officer | 27 Feb 2025 | 52,000 | 52,000 | - | - | Employee Stock Option (right to buy) | ||
| Mr. Mark Hopman | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 35,000 | 35,000 | - | 0 | Common Stock | |
| Mr. Sean D. Carney | Director | 31 Jan 2025 | 30,456 | 30,456 | - | - | Director Stock Option (right to buy) | ||
| Mr. Sean D. Carney | Director | 31 Jan 2025 | 55,837 | 55,837 | - | - | Director Stock Option (right to buy) | ||
| Dr. Maria Palasis, PhD | Director | 31 Jan 2025 | 9,137 | 9,137 | - | - | Director Stock Option (right to buy) | ||
| Mr. Sean Saint | Director, President & CEO | 31 Jan 2025 | 467,944 | 467,944 | - | - | Employee Stock Option (right to buy) | ||
| Mr. Sean Saint | Director, President & CEO | 31 Jan 2025 | 54,911 | 54,911 | - | - | Employee Stock Option (right to buy) | ||
| Mr. Sean Saint | Director, President & CEO | 31 Jan 2025 | 494,198 | 494,198 | - | - | Employee Stock Option (right to buy) | ||
| Mr. Sean Saint | Director, President & CEO | 31 Jan 2025 | 83,268 | 83,268 | - | - | Employee Stock Option (right to buy) | ||
| Mr. Sean Saint | Director, President & CEO | 31 Jan 2025 | 749,445 | 749,445 | - | - | Employee Stock Option (right to buy) | ||
| Mr. Stephen Feider | Chief Financial Officer | 31 Jan 2025 | 166,542 | 166,542 | - | - | Employee Stock Option (right to buy) | ||
| Mr. Stephen Feider | Chief Financial Officer | 31 Jan 2025 | 186,203 | 186,203 | - | - | Employee Stock Option (right to buy) | ||
| Mr. Stephen Feider | Chief Financial Officer | 31 Jan 2025 | 109,695 | 109,695 | - | - | Employee Stock Option (right to buy) | ||
| Mr. Mike Mensinger | Chief Product Officer | 31 Jan 2025 | 110,278 | 110,278 | - | - | Employee Stock Option (right to buy) | ||
| Mr. Mike Mensinger | Chief Product Officer | 31 Jan 2025 | 236,553 | 236,553 | - | - | Employee Stock Option (right to buy) | ||
| Mr. Mike Mensinger | Chief Product Officer | 31 Jan 2025 | 10,575 | 0 | - | - | Class B Common Stock Warrant (right to buy) | ||
| Mr. Mike Mensinger | Chief Product Officer | 31 Jan 2025 | 10,575 | 10,575 | - | - | Class B Common Stock Warrant (right to buy) | ||
| Mr. Mike Mensinger | Chief Product Officer | 31 Jan 2025 | 15,107 | 0 | - | - | Series D Preferred Stock | ||
| Mr. Mike Mensinger | Chief Product Officer | Purchase of securities on an exchange or from another person at price $ 17.00 per share. | 31 Jan 2025 | 33,350 | 59,019 | - | 17 | 566,950 | Common Stock |
| Mr. Mike Mensinger | Chief Product Officer | Sale of securities on an exchange or to another person at price $ 17.00 per share. | 31 Jan 2025 | 13 | 25,669 | - | 17 | 221 | Common Stock |
| Mr. Mike Mensinger | Chief Product Officer | 31 Jan 2025 | 10,575 | 25,682 | - | 0.0 | 212 | Common Stock | |
| Mr. Mike Mensinger | Chief Product Officer | 31 Jan 2025 | 15,107 | 15,107 | - | - | Common Stock | ||
| Dr. Steven Russell, M.D.,PhD | Chief Medical Officer | 31 Jan 2025 | 81,217 | 81,217 | - | - | Employee Stock Option (right to buy) | ||
| Dr. Steven Russell, M.D.,PhD | Chief Medical Officer | 31 Jan 2025 | 90,637 | 90,637 | - | - | Employee Stock Option (right to buy) | ||
| Dr. Steven Russell, M.D.,PhD | Chief Medical Officer | 31 Jan 2025 | 53,584 | 53,584 | - | - | Employee Stock Option (right to buy) | ||
| Mr. Adam Lezack, PhD | Director | 31 Jan 2025 | 9,137 | 9,137 | - | - | Director Stock Option (right to buy) | ||
| Ms. Christy Jones | Director | 31 Jan 2025 | 9,137 | 9,137 | - | - | Director Stock Option (right to buy) | ||
| Ms. Christy Jones | Director | 31 Jan 2025 | 48,730 | 48,730 | - | - | Director Stock Option (right to buy) | ||
| Ms. Christy Jones | Director | 31 Jan 2025 | 9,137 | 9,137 | - | - | Director Stock Option (right to buy) | ||
| Mr. Mark Hopman | Chief Commercial Officer | 31 Jan 2025 | 17,765 | 17,765 | - | - | Employee Stock Option (right to buy) | ||
| Mr. Mark Hopman | Chief Commercial Officer | 31 Jan 2025 | 83,242 | 83,242 | - | - | Employee Stock Option (right to buy) | ||
| Mr. Mark Hopman | Chief Commercial Officer | 31 Jan 2025 | 37,229 | 37,229 | - | - | Employee Stock Option (right to buy) | ||
| Mr. Mark Hopman | Chief Commercial Officer | 31 Jan 2025 | 39,424 | 39,424 | - | - | Employee Stock Option (right to buy) | ||
| Mr. Mark Hopman | Chief Commercial Officer | 31 Jan 2025 | 47,775 | 47,775 | - | - | Employee Stock Option (right to buy) | ||
| Mr. Sean Saint | Director, President & CEO | 29 Jan 2025 | 467,944 | 467,944 | - | - | Employee Stock Option (right to buy) | ||
| Mr. Stephen Feider | Chief Financial Officer | 29 Jan 2025 | 186,203 | 186,203 | - | - | Employee Stock Option (right to buy) | ||
| Mr. Mike Mensinger | Chief Product Officer | 29 Jan 2025 | 110,278 | 110,278 | - | - | Employee Stock Option (right to buy) | ||
| Dr. Steven Russell, M.D.,PhD | Chief Medical Officer | 29 Jan 2025 | 90,637 | 90,637 | - | - | Employee Stock Option (right to buy) | ||
| Mr. Mark Hopman | Chief Commercial Officer | 29 Jan 2025 | 47,775 | 47,775 | - | - | Employee Stock Option (right to buy) |